Hoberman Kenneth
SEC insider (Form 3/4/5 filer). CIK 0001573722. Director at TG THERAPEUTICS, INC. (TGTX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in FORT LEE, NJ.
Companies Hoberman Kenneth has filed insider reports for
- TG THERAPEUTICS, INC. (TGTX): Director
- Nuvectis Pharma, Inc. (NVCT): Director
Hoberman Kenneth
CIK: 0001573722
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 11, 2026TGTX
TG THERAPEUTICS, INC.
AwardDirectStock Tracking Unit
8.3K shares- - Jun 11, 2026NVCT
Nuvectis Pharma, Inc.
AwardDirect35K shares- - Jun 12, 2025TGTX
TG THERAPEUTICS, INC.
AwardDirect14.7K shares- - Jun 12, 2025NVCT
Nuvectis Pharma, Inc.
AwardDirect30K shares-
1-4 of 4 transactions